Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, Elliott DA, Lawrence TS, Hearn J, Hayman JA, Jolly S.
Edwards DM, et al. Among authors: arenberg da.
Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749-1. doi: 10.1016/j.ijrobp.2024.06.018. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 38971385